23 September New research reveals devastating impact of living with migraine, yet condition still not taken seriously

13 September Lord Darzi’s report into NHS England highlights key gaps in care

21 June New research project funded by The Migraine Trust to understand how to avert a migraine attack at the earliest stage

12 June Our new strategy:2024-2027

10 June Migraine News: 2024 Edition

23 May Migraine care is lacking across the UK but for Northern Ireland, the situation is dire

11 April NICE announces approval of Atogepant for preventive use on the NHS in England

25 March MPs debate migraine in Parliament after sixty years and call for better migraine care

14 September NICE approves Rimegepant for acute use on the NHS in England

11 September Rimegepant approved for preventative use in Scotland

3 July Research reveals that over a third of people have experienced discrimination at work because of their migraines

31 May NICE approves migraine medication Rimegepant for preventive use on the NHS in England

25 May The Migraine Trust Fellowship recipients announced

9 May SMC approves migraine medication Rimegepant for acute treatment use on the NHS in Scotland

11 April Celebrating March for Migraine 2023

24 March Read the latest edition of our magazine, Migraine News

21 February NICE rejects migraine medication Rimegepant for use on the NHS in England

13 February SMC approves eptinezumab (Vyepti) to treat episodic and chronic migraine

2 February New clinical care pathway for the UK’s 10 million people with migraine

25 January NICE approves eptinezumab (Vyepti) to treat episodic and chronic migraine

14 November Two new fellowships launched

16 September Susan Haydon Bursary recipient publishes migraine and genetics research

8 September Read the latest edition of our magazine, Migraine News

4 September Children and young people with migraine need change now

16 June Donna’s charity golf day for people with migraine

26 May New migraine toolkit launched for UK parliamentarians

11 May Professor Peter Goadsby elected Fellow of the Royal Society

4 April Celebrating March for Migraine 2022

16 September NICE approves fremanezumab (Ajovy) for episodic migraine

5 September New report highlights broken UK migraine healthcare system

22 April Professor Peter Goadsby wins this year’s Scientific Breakthrough Award

12 April Galcanezumab approved for use within NHS Scotland

5 April First Susan Haydon bursaries awarded

11 March Dr Joseph Lloyd awarded PhD for his migraine research

4 March Ground-breaking migraine researchers win this year’s Brain Prize